Application of Biochips in Drug Discovery & Development, Genomics and In Vitro Diagnostics

Biochips are a collection of microarrays which are arranged on a solid substrate that enables numerous biochemical reactions such as decoding of genes in a few seconds. In addition, biochips are designed to function in biological environments and are capable of detecting and measuring a large number of biomarkers and perform complex biochemical reactions simultaneously in a very short span of time. Biochips are capable of performing a multitude of biochemical reactions simultaneously and with ease. Furthermore, these chips also help in identifying gene sequences and analyzing proteins in human and animal bodies. In in vitro diagnostics, biochips are extensively used to detect the symptoms of diseases and provide effective cures for the same. These chips are also of help in conducting tests for analyzing pandemics, glucose monitoring, drug tests, and diabetic diagnosis, and control of various diseases.

Information of Biochips at: http://bit.ly/1Wv8w7H

Biochips enable precise and accurate modelling of physiological situations for fundamental research and drug development, alike. Moreover, the chips also help in carrying out high-volume tests associated with various aspects of drug discovery and development. Furthermore, the advent of biochips has also revolutionized molecular diagnostics in identifying the presence of viruses, bacteria, or other organisms in patient samples for monitoring viral responses to the therapy and detecting genetic disorders.

However, on the flip side, companies involved in manufacturing biochips have to comply with stringent regulations related to medical devices such as United States Pharmacopeia (USP) and Clinical and Laboratory Standards Institute (CLSI), among others. Such regulations are viewed as major bottlenecks by large companies operating in the market.

Increasing application of biochips in the medical sector for cancer treatment, drug research, and diagnostics is one of the major factors driving the growth of the global biochips market. In addition, factors such as availability of molecular information, automation of biochemical processes through the use of biochips and application of biochips for gene and protein identification are set to drive the global biochips market.

The use of biochips has brought about a transition in the field of drug discovery and research. Biochips have the ability to detect cancer before its symptoms develop in human bodies. In addition, it can easily detect virulent diseases such as smallpox, anthrax, and plague in a very short span of time. Moreover, biochips are increasingly finding application in veterinary diagnostics. Biochips comprise grids that may be dots or small wells. Each grid contains nucleic acid or antibodies and proteins which bind to a DNA sequence or a target antigen. The abundance of proteomics and genetics data coupled with the need for identifying gene sequences and proteins in human beings is driving the biochips market. Conventional gene and protein sequencing methods cannot provide qualitative output and are ineffective whereas biochips are extremely effective and produce accurate gene sequencing results in a very short span of time. Significant growth in the healthcare sector, rising demands for diagnostics and increasing medical expenditure coupled with economic reforms in major developing countries has been able to bolster the growth of Biochips market.

Biochips